Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Renou

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Journal of Gastroenterology and Hepatology|May 9, 2006
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: complete biochemical and histological response to therapy with ursodesoxycholic acidChristophe Renou, Marc Bourlière, François Martini, et al.
Clinics and Research in Hepatology and Gastroenterology|July 19, 2014
Impact of IL28B on the treatment decision in naïve and experienced patients with genotype 1 and 4 chronic hepatitis C in real-life clinical practice: a prospective multicenter cohortPhilippe Halfon, Denis Ouzan, Tarik Asselah, et al.
European Journal of Gastroenterology & Hepatology|November 8, 2008
Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriersChristophe Renou, Jean-François Cadranel, Alexandre Pariente, et al.
Journal of Hepatology|December 13, 2006
Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis CPhilippe Halfon, Yannick Bacq, Anne De Muret, et al.
Hepatology (Baltimore, Md.)|September 13, 2016
Hepatitis E in decompensated alcoholic cirrhosisChristophe Renou, Bruno Lesgourgues, Gilles Macaigne, et al.
European Journal of Gastroenterology & Hepatology|September 9, 2011
A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virusPhilippe Halfon, Marc Bourliere, Denis Ouzan, et al.
Journal of Hepatology|February 25, 2016
HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvirHarel Dahari, Laetitia Canini, Frederik Graw, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 17, 2015
Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective studyJean Marie Péron, Florence Abravanel, Maeva Guillaume, et al.
Journal of Hepatology|July 14, 2006
Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter studyVictor de Lédinghen, Vlad Ratziu, Xavier Causse, et al.
Journal of Hepatology|December 15, 2010
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitisVlad Ratziu, Victor de Ledinghen, Fréderic Oberti, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of Gastroenterology and Hepatology|May 9, 2006
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: complete biochemical and histological response to therapy with ursodesoxycholic acidChristophe Renou, Marc Bourlière, François Martini, et al.
Clinics and Research in Hepatology and Gastroenterology|July 19, 2014
Impact of IL28B on the treatment decision in naïve and experienced patients with genotype 1 and 4 chronic hepatitis C in real-life clinical practice: a prospective multicenter cohortPhilippe Halfon, Denis Ouzan, Tarik Asselah, et al.
European Journal of Gastroenterology & Hepatology|November 8, 2008
Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriersChristophe Renou, Jean-François Cadranel, Alexandre Pariente, et al.
Journal of Hepatology|December 13, 2006
Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis CPhilippe Halfon, Yannick Bacq, Anne De Muret, et al.
Hepatology (Baltimore, Md.)|September 13, 2016
Hepatitis E in decompensated alcoholic cirrhosisChristophe Renou, Bruno Lesgourgues, Gilles Macaigne, et al.
European Journal of Gastroenterology & Hepatology|September 9, 2011
A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virusPhilippe Halfon, Marc Bourliere, Denis Ouzan, et al.
Journal of Hepatology|February 25, 2016
HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvirHarel Dahari, Laetitia Canini, Frederik Graw, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 17, 2015
Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective studyJean Marie Péron, Florence Abravanel, Maeva Guillaume, et al.
Journal of Hepatology|July 14, 2006
Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter studyVictor de Lédinghen, Vlad Ratziu, Xavier Causse, et al.
Journal of Hepatology|December 15, 2010
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitisVlad Ratziu, Victor de Ledinghen, Fréderic Oberti, et al.
Pageof 6